apollo
0
Written By Lakshmithulasi Yarragunta , Pharm-D (PB)
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Non returnable*
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

OFATUMUMAB-1000MG

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

About Arzerra 1000mg Solution for Infusion

Arzerra 1000mg Solution for Infusion is an anti-cancer medicine used in the treatment of cancer. The intravenous route of this medicine is used in combination with chlorambucil for the treatment of CLL in patients for whom fludarabine-based therapy is considered inappropriate and as an extended treatment in patients who have a partial response after at least two lines of therapy. Chronic lymphocytic leukaemia is a cancer that occurs in the bone marrow and blood. The subcutaneous route of the medicine is used in treating relapsing forms of multiple sclerosis. It is a condition in which the immune system attacks the protective covering of the nerves called myelin.

Arzerra 1000mg Solution for Infusion contains Ofatumumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.

Arzerra 1000mg Solution for Infusion may cause certain side effects, such as nausea, vomiting, diarrhoea, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Arzerra 1000mg Solution for Infusion. Hence, do not self-administer.

While taking Arzerra 1000mg Solution for Infusion if you experience any allergic reaction, inform your doctor. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Arzerra 1000mg Solution for Infusion is known to cause fetal B-cell depletion in neonates. Hence, inform your physician if you are pregnant beforehand. Breastfeeding mothers should avoid taking Arzerra 1000mg Solution for Infusion.

Uses of Arzerra 1000mg Solution for Infusion

Chronic Lymphocytic Leukemia, Multiple sclerosis.

Directions for Use

A trained healthcare professional will administer Arzerra 1000mg Solution for Infusion. Hence, do not self-administer. The dose of the medicine will be decided by your oncologist based on the severity of your condition. Chronic lymphocytic leukemia: Arzerra 1000mg Solution for Infusion should only be administered intravenously. Avoid giving it through the SC route or as an intravenous bolus or push.Multiple sclerosis: Arzerra 1000mg Solution for Infusion should be administered through subcutaneous route only. Avoid giving it via IV or IM route.

Medicinal Benefits

Arzerra 1000mg Solution for Infusion contains Ofatumumab, which belongs to the class of CD20-directed cytolytic antibodies. It is used in the treatment of chronic lymphocytic leukaemia. This medicine works by binding to the CD20 antibody and causes lysis of B-cell lymphocytes responsible for the multiplication of cancer cells. This causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Arzerra 1000mg Solution for Infusion should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Arzerra 1000mg Solution for Infusion may cause remission of active infections, severe skin reactions, tumour lysis syndrome (tumour cells release their contents into the bloodstream), hepatitis B virus reactivation, progressive multifocal leukoencephalopathy, and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Arzerra 1000mg Solution for Infusion may cause fetal B-cell depletion in infants. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Arzerra 1000mg Solution for Infusion is not recommended for use in children as the safety and efficacy are not established.

Diet & Lifestyle Advise

  • After your treatment begins, dietary adjustments can help you control side effects.
  • Anyone suffering from a chronic illness, including cancer, should consume foods high in protein, healthy fats, whole grains, and vitamins and minerals.
  • Plant-based proteins are among the greatest meals to take during chemotherapy or other cancer treatments. They have the highest concentrations of vitamins and minerals, such as nuts, seeds, beans, and legumes.
  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
  • Get optimal sleep; rest well.
  • Avoid smoking and alcohol consumption.
  • Avoid fast and fried food, processed meats, refined carbs and added sugars.

Habit Forming

No

Therapeutic Class

ANTINEOPLASTIC

FAQs

Arzerra 1000mg Solution for Infusion contains Ofatumumab, which works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells

Arzerra 1000mg Solution for Infusion may cause reactivation of serious infections, tumour lysis syndrome, hepatitis B virus reactivation, progressive multifocal leukoencephalopathy, and anaphylactic reactions in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.

Special Advise

  • A blood test should be performed, such as a liver function test or renal function test, to check for liver/kidney function.
  • Weekly blood tests should be done during the treatment to check for CBC (Complete blood count).

Disease/Condition Glossary

Chronic Lymphocytic Leukaemia: It is a type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.

Multiple sclerosis: Multiple sclerosis is a condition that affects the brain and spinal cord. The immune system attacks the protective covering of the nerves (myelin) and causes disrupted communication between the brain and body due to nerve damage.  This causes symptoms such as problems with sensation, balance, vision, pain, impaired coordination, and fatigue.

Have a query?

whatsapp Floating Button